{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:51:20Z","timestamp":1761598280180,"version":"3.37.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA18206"],"award-info":[{"award-number":["CA18206"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Biol. Eng."],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>There is an annual incidence of 50,000 glioma cases in Europe. The optimal treatment strategy is highly personalised, depending on tumour type, grade, spatial localization, and the degree of tissue infiltration. In research settings, advanced magnetic resonance imaging (MRI) has shown great promise as a tool to inform personalised treatment decisions. However, the use of advanced MRI in clinical practice remains scarce due to the downstream effects of siloed glioma imaging research with limited representation of MRI specialists in established consortia; and the associated lack of available tools and expertise in clinical settings. These shortcomings delay the translation of scientific breakthroughs into novel treatment strategy. As a response we have developed the network \u201cGlioma MR Imaging 2.0\u201d (GliMR) which we present in this article.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>GliMR aims to build a pan-European and multidisciplinary network of experts and accelerate the use of advanced MRI in glioma beyond the current \u201cstate-of-the-art\u201d in glioma imaging. The Action Glioma MR Imaging 2.0 (GliMR) was granted funding by the European Cooperation in Science and Technology (COST) in June 2019.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>GliMR\u2019s first grant period ran from September 2019 to April 2020, during which several meetings were held and projects were initiated, such as reviewing the current knowledge on advanced MRI; developing a General Data Protection Regulation (GDPR) compliant consent form; and setting up the website.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The Action overcomes the pre-existing limitations of glioma research and is funded until September 2023. New members will be accepted during its entire duration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40846-020-00582-z","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T13:03:01Z","timestamp":1607000581000},"page":"115-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for Glioma"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8546-0134","authenticated-orcid":false,"given":"Patricia","family":"Clement","sequence":"first","affiliation":[]},{"given":"Thomas","family":"Booth","sequence":"additional","affiliation":[]},{"given":"Fran","family":"Borove\u010dki","sequence":"additional","affiliation":[]},{"given":"Kyrre E.","family":"Emblem","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Figueiredo","sequence":"additional","affiliation":[]},{"given":"Lydiane","family":"Hirschler","sequence":"additional","affiliation":[]},{"given":"Radim","family":"Jan\u010d\u00e1lek","sequence":"additional","affiliation":[]},{"given":"Vera C.","family":"Keil","sequence":"additional","affiliation":[]},{"given":"Camille","family":"Maumet","sequence":"additional","affiliation":[]},{"given":"Yelda","family":"\u00d6zsunar","sequence":"additional","affiliation":[]},{"given":"Cyril","family":"Pernet","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Petr","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Marion","family":"Smits","sequence":"additional","affiliation":[]},{"given":"Esther A. H.","family":"Warnert","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"582_CR1","unstructured":"ECIS\u2014European Cancer Information System. (2018). Estimates of cancer incidence and mortality in 2018. Retrieved June 19, 2020, from https:\/\/ecis.jrc.ec.europa.eu\/explorer.php?$0-0$1-All$2-All$4-1,2$3-44$6-0,85$5-2008,2008$7-7$CEstByCountry$X0_8-3$X0_19-AE28E$X0_20-No$CEstRelative$X1_8-3$X1_9-AE28$X1_19-AE28E$CEstByCountryTable$X2_19-AE28E."},{"issue":"4","key":"582_CR2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-015-1398-z","volume":"129","author":"A Olar","year":"2015","unstructured":"Olar, A., Wani, K. M., Alfaro-Munoz, K. D., Heathcock, L. E., van Thuijl, H. F., Gilbert, M. R., et al. (2015). IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathologica, 129(4), 585\u2013596.","journal-title":"Acta Neuropathologica"},{"issue":"6491","key":"582_CR3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1126\/science.aaz2078","volume":"368","author":"N Pashayan","year":"2020","unstructured":"Pashayan, N., & Pharoah, P. D. P. (2020). The challenge of early detection in cancer. Science, 368(6491), 589\u2013590.","journal-title":"Science"},{"issue":"6","key":"582_CR4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., et al. (2016). The 2016 World Health Organization classification of tumors of the Central Nervous System: A summary. Acta Neuropathologica, 131(6), 803\u2013820.","journal-title":"Acta Neuropathologica"},{"key":"582_CR5","unstructured":"Eurostat\u2014Statistics. (2019). Use of imaging equipment\u2014number of magnetic resonance imaging (MRI) scans, 2017. Retrieved June 19, 2020, from https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Healthcare_resource_statistics_-_technical_resources_and_medical_technology."},{"issue":"3","key":"582_CR6","first-page":"239","volume":"62","author":"WB Pope","year":"2018","unstructured":"Pope, W. B., & Brandal, G. (2018). Conventional and advanced magnetic resonance imaging in patients with high-grade glioma. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 62(3), 239\u2013253.","journal-title":"The Quarterly Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"11","key":"582_CR7","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/neuonc\/noy095","volume":"20","author":"A Falk Delgado","year":"2018","unstructured":"Falk Delgado, A., De Luca, F., van Westen, D., & Falk Delgado, A. (2018). Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma\u2014A meta-analysis. Neuro Oncology, 20(11), 1450\u20131461.","journal-title":"Neuro Oncology"},{"issue":"3","key":"582_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11940-017-0445-6","volume":"19","author":"H Hyare","year":"2017","unstructured":"Hyare, H., Thust, S., & Rees, J. (2017). Advanced MRI techniques in the monitoring of treatment of gliomas. Current Treatment Options in Neurology, 19(3), 11.","journal-title":"Current Treatment Options in Neurology"},{"issue":"1","key":"582_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jmri.21991","volume":"31","author":"J Weis","year":"2010","unstructured":"Weis, J., Ring, P., Olofsson, T., Ortiz-Nieto, F., & Wikstr\u00f6m, J. (2010). Short echo time MR spectroscopy of brain tumors: Grading of cerebral gliomas by correlation analysis of normalized spectral amplitudes. Journal of Magnetic Resonance Imaging, 31(1), 39\u201345.","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"2","key":"582_CR10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3174\/ajnr.A3686","volume":"35","author":"C Federau","year":"2014","unstructured":"Federau, C., Meuli, R., O\u2019Brien, K., Maeder, P., & Hagmann, P. (2014). Perfusion measurement in brain gliomas with intravoxel incoherent motion MRI. American Journal of Neuroradiology, 35(2), 256\u2013262.","journal-title":"American Journal of Neuroradiology"},{"issue":"2","key":"582_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1515\/raon-2017-0010","volume":"51","author":"AF Delgado","year":"2017","unstructured":"Delgado, A. F., Fahlstr\u00f6m, M., Nilsson, M., Berntsson, S. G., Zetterling, M., Libard, S., et al. (2017). Diffusion Kurtosis imaging of gliomas grades II and III\u2014A study of perilesional tumor infiltration, tumor grades and subtypes at clinical presentation. Radiology Oncology, 51(2), 121\u2013129.","journal-title":"Radiology Oncology"},{"issue":"5","key":"582_CR12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/RCT.0b013e318261e913","volume":"36","author":"FE De Belder","year":"2012","unstructured":"De Belder, F. E., Oot, A. R., Van Hecke, W., Venstermans, C., Menovsky, T., Van Marck, V., et al. (2012). Diffusion tensor imaging provides an insight into the microstructure of meningiomas, high-grade gliomas, and peritumoral edema. Journal of Computer Assisted Tomography, 36(5), 577\u2013582.","journal-title":"Journal of Computer Assisted Tomography"},{"issue":"7","key":"582_CR13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00234-020-02425-9","volume":"62","author":"G Abdalla","year":"2020","unstructured":"Abdalla, G., Dixon, L., Sanverdi, E., Machado, P. M., Kwong, J. S. W., Panovska-Griffiths, J., et al. (2020). The diagnostic role of diffusional kurtosis imaging in glioma grading and differentiation of gliomas from other intra-axial brain tumours: A systematic review with critical appraisal and meta-analysis. Neuroradiology, 62(7), 791\u2013802.","journal-title":"Neuroradiology"},{"issue":"1","key":"582_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3174\/ajnr.A5415","volume":"39","author":"KM Pepin","year":"2018","unstructured":"Pepin, K. M., McGee, K. P., Arani, A., Lake, D. S., Glaser, K. J., Manduca, A., et al. (2018). MR elastography analysis of glioma stiffness and IDH1-mutation status. American Journal of Neuroradiology, 39(1), 31\u201336.","journal-title":"American Journal of Neuroradiology"},{"issue":"2","key":"582_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11060-013-1210-7","volume":"115","author":"V T\u00f3th","year":"2013","unstructured":"T\u00f3th, V., F\u00f6rschler, A., Hirsch, N. M., den Hollander, J., Kooijman, H., Gempt, J., et al. (2013). MR-based hypoxia measures in human glioma. Journal of Neuro-Oncology, 115(2), 197\u2013207.","journal-title":"Journal of Neuro-Oncology"},{"issue":"9","key":"582_CR16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/nm.3289","volume":"19","author":"KE Emblem","year":"2013","unstructured":"Emblem, K. E., Mouridsen, K., Bjornerud, A., Farrar, C. T., Jennings, D., Borra, R. J. H., et al. (2013). Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nature Medicine, 19(9), 1178\u20131183.","journal-title":"Nature Medicine"},{"issue":"9","key":"582_CR17","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s00330-018-5335-0","volume":"28","author":"CH Suh","year":"2018","unstructured":"Suh, C. H., Kim, H. S., Jung, S. C., Choi, C. G., & Kim, S. J. (2018). Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: A systematic review and meta-analysis. European Radiology, 28(9), 3819\u20133831.","journal-title":"European Radiology"},{"issue":"2","key":"582_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/cns.12.25","volume":"1","author":"KM Schmainda","year":"2012","unstructured":"Schmainda, K. M. (2012). Diffusion-weighted MRI as a biomarker for treatment response in glioma. CNS Oncology, 1(2), 169\u2013180.","journal-title":"CNS Oncology"},{"issue":"5","key":"582_CR19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3174\/ajnr.A5112","volume":"38","author":"PD Chang","year":"2017","unstructured":"Chang, P. D., Malone, H. R., Bowden, S. G., Chow, D. S., Gill, B. J. A., Ung, T. H., et al. (2017). A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies. American Journal of Neuroradiology, 38(5), 890\u2013898.","journal-title":"American Journal of Neuroradiology"},{"issue":"1","key":"582_CR20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2214\/AJR.17.18754","volume":"210","author":"D Chow","year":"2018","unstructured":"Chow, D., Chang, P., Weinberg, B. D., Bota, D. A., Grinband, J., & Filippi, C. G. (2018). Imaging genetic heterogeneity in glioblastoma and other glial tumors: Review of current methods and future directions. American Journal of Roentgenology, 210(1), 30\u201338.","journal-title":"American Journal of Roentgenology"},{"key":"582_CR21","unstructured":"Warnert, E. A. H., Incekara, F., Van den Bent, M., Vincent, A., Dirven, C., & Wood, T. et al. (2017). Multi-parametric physiology mapping of non-enhacing gliomas in humans. Presented at the Proc of the 34th annual meeting of the European society of magnetic resonance in medicine and biology, Barcelona, P320."},{"issue":"3","key":"582_CR22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1148\/radiol.2016161382","volume":"281","author":"P Kickingereder","year":"2016","unstructured":"Kickingereder, P., Bonekamp, D., Nowosielski, M., Kratz, A., Sill, M., Burth, S., et al. (2016). Radiogenomics of glioblastoma: Machine learning-based classification of molecular characteristics by using multiparametric and multiregional MR imaging features. Radiology, 281(3), 907\u2013918.","journal-title":"Radiology"},{"key":"582_CR23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/OTT.S50208","volume":"6","author":"N Thon","year":"2013","unstructured":"Thon, N., Kreth, S., & Kreth, F. W. (2013). Personalized treatment strategies in glioblastoma: MGMT promoter methylation status. Onco Targets and Therapy, 6, 1363\u20131372.","journal-title":"Onco Targets and Therapy"},{"issue":"22","key":"582_CR24","doi-asserted-by":"crossref","first-page":"R323","DOI":"10.1088\/0031-9155\/60\/22\/R323","volume":"60","author":"MA Schmidt","year":"2015","unstructured":"Schmidt, M. A., & Payne, G. S. (2015). Radiotherapy planning using MRI. Physics in Medicine and Biology, 60(22), R323-361.","journal-title":"Physics in Medicine and Biology"},{"issue":"1","key":"582_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13014-016-0747-y","volume":"12","author":"JM Edmund","year":"2017","unstructured":"Edmund, J. M., & Nyholm, T. (2017). A review of substitute CT generation for MRI-only radiation therapy. Radiation Oncology, 12(1), 28.","journal-title":"Radiation Oncology"},{"issue":"9490","key":"582_CR26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","volume":"366","author":"MJ van den Bent","year":"2005","unstructured":"van den Bent, M. J., Afra, D., de Witte, O., Ben Hassel, M., Schraub, S., Hoang-Xuan, K., et al. (2005). Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet, 366(9490), 985\u2013990.","journal-title":"Lancet"},{"issue":"1","key":"582_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11060-009-9991-4","volume":"97","author":"C Hlaihel","year":"2010","unstructured":"Hlaihel, C., Guilloton, L., Guyotat, J., Streichenberger, N., Honnorat, J., & Cotton, F. (2010). Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. Journal of Neuro-oncology, 97(1), 73\u201380.","journal-title":"Journal of Neuro-oncology"},{"key":"582_CR28","doi-asserted-by":"crossref","first-page":"5813951","DOI":"10.1155\/2017\/5813951","volume":"2017","author":"D Aquino","year":"2017","unstructured":"Aquino, D., Gioppo, A., Finocchiaro, G., Bruzzone, M. G., & Cuccarini, V. (2017). MRI in glioma immunotherapy: Evidence, pitfalls, and perspectives. J Immunol Res, 2017, 5813951.","journal-title":"J Immunol Res"},{"issue":"14","key":"582_CR29","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1158\/1078-0432.CCR-16-2265","volume":"23","author":"H Mehrabian","year":"2017","unstructured":"Mehrabian, H., Desmond, K. L., Soliman, H., Sahgal, A., & Stanisz, G. J. (2017). Differentiation between radiation necrosis and tumor progression using chemical exchange saturation transfer. Clinical Cancer Research, 23(14), 3667\u20133675.","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"582_CR30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3174\/ajnr.A4474","volume":"37","author":"S Wang","year":"2016","unstructured":"Wang, S., Martinez-Lage, M., Sakai, Y., Chawla, S., Kim, S. G., Alonso-Basanta, M., et al. (2016). Differentiating tumor progression from pseudoprogression in patients with glioblastomas using diffusion tensor imaging and dynamic susceptibility contrast MRI. American Journal of Neuroradiology, 37(1), 28\u201336.","journal-title":"American Journal of Neuroradiology"},{"issue":"1","key":"582_CR31","doi-asserted-by":"crossref","first-page":"17062","DOI":"10.1038\/s41598-018-34820-x","volume":"8","author":"KI Ly","year":"2018","unstructured":"Ly, K. I., Vakulenko-Lagun, B., Emblem, K. E., Ou, Y., Da, X., Betensky, R. A., et al. (2018). Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Scientific Reports, 8(1), 17062.","journal-title":"Scientific Reports"},{"key":"582_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2019.05.020","volume":"140","author":"J K\u0142os","year":"2019","unstructured":"K\u0142os, J., van Laar, P. J., Sinnige, P. F., Enting, R. H., Kramer, M. C. A., van der Weide, H. L., et al. (2019). Quantifying effects of radiotherapy-induced microvascular injury; review of established and emerging brain MRI techniques. Radiotherapy and Oncology, 140, 41\u201353.","journal-title":"Radiotherapy and Oncology"},{"issue":"12","key":"582_CR33","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1073\/pnas.1323855111","volume":"111","author":"K Sagiyama","year":"2014","unstructured":"Sagiyama, K., Mashimo, T., Togao, O., Vemireddy, V., Hatanpaa, K. J., Maher, E. A., et al. (2014). In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proceedings of the National Academy of Science USA, 111(12), 4542\u20134547.","journal-title":"Proceedings of the National Academy of Science USA"},{"issue":"1","key":"582_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2017.11.033","volume":"128","author":"J Petr","year":"2018","unstructured":"Petr, J., Platzek, I., Hofheinz, F., Mutsaerts, H., Asllani, I., van Osch, M. J. P., et al. (2018). Photon vs proton radiochemotherapy: Effects on brain tissue volume and perfusion. Radiotherapy and Oncology, 128(1), 121\u2013127.","journal-title":"Radiotherapy and Oncology"},{"issue":"1","key":"582_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2016.01.003","volume":"118","author":"RA Karunamuni","year":"2016","unstructured":"Karunamuni, R. A., Moore, K. L., Seibert, T. M., Li, N., White, N. S., Bartsch, H., et al. (2016). Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging. Radiotherapy and Oncology, 118(1), 29\u201334.","journal-title":"Radiotherapy and Oncology"},{"issue":"1","key":"582_CR36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","volume":"128","author":"M Lambrecht","year":"2018","unstructured":"Lambrecht, M., Eekers, D. B. P., Alapetite, C., Burnet, N. G., Calugaru, V., Coremans, I. E. M., et al. (2018). Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology, 128(1), 26\u201336.","journal-title":"Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"1","key":"582_CR37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5732\/cjc.013.10214","volume":"33","author":"L Dirven","year":"2014","unstructured":"Dirven, L., Aaronson, N. K., Heimans, J. J., & Taphoorn, M. J. (2014). Health-related quality of life in high-grade glioma patients. Chinese Journal of Cancer, 33(1), 40\u201345.","journal-title":"Chinese Journal of Cancer"},{"issue":"8","key":"582_CR38","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1007\/s00330-018-5314-5","volume":"28","author":"SC Thust","year":"2018","unstructured":"Thust, S. C., Heiland, S., Falini, A., J\u00e4ger, H. R., Waldman, A. D., Sundgren, P. C., et al. (2018). Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice. European Radiology, 28(8), 3306\u20133317.","journal-title":"European Radiology"},{"issue":"6","key":"582_CR39","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.3174\/ajnr.A4341","volume":"36","author":"K Welker","year":"2015","unstructured":"Welker, K., Boxerman, J., Kalnin, A., Kaufmann, T., Shiroishi, M., & Wintermark, M. (2015). ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR. American Journal of Neuroradiology, 36(6), E41-51.","journal-title":"AJNR. American Journal of Neuroradiology"},{"issue":"1","key":"582_CR40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2214\/AJR.18.20218","volume":"212","author":"E Lotan","year":"2019","unstructured":"Lotan, E., Jain, R., Razavian, N., Fatterpekar, G. M., & Lui, Y. W. (2019). State of the art: Machine learning applications in glioma imaging. American Journal of Roentgenology, 212(1), 26\u201337.","journal-title":"American Journal of Roentgenology"},{"key":"582_CR41","unstructured":"EORTC. (2019). European Organisation for Research and Treatment of Cancer. Retrieved June 19, 2020, from https:\/\/www.eortc.org\/."},{"key":"582_CR42","unstructured":"Cavallini, S., Soldi, R., Di Matteo, L., Utma, M. A., & Errico, B. (2018). Addressing brain drain: The local and regional dimension. Retrieved June 19, 2020, from https:\/\/cor.europa.eu\/en\/engage\/studies\/Documents\/addressing-brain-drain\/addressing-brain-drain.pdf."},{"issue":"8","key":"582_CR43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00586-008-0699-5","volume":"17","author":"D Delawi","year":"2008","unstructured":"Delawi, D., Dhert, W. J., & Oner, F. C. (2008). Conducting a European multi-center trial: First experiences with the new EU Clinical Trials Directive from an academic perspective. European Spine Journal, 17(8), 1113\u20131115.","journal-title":"European Spine Journal"},{"issue":"4","key":"582_CR44","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jmri.25963","volume":"48","author":"A Fathi Kazerooni","year":"2018","unstructured":"Fathi Kazerooni, A., Nabil, M., Zeinali Zadeh, M., Firouznia, K., Azmoudeh-Ardalan, F., Frangi, A. F., et al. (2018). Characterization of active and infiltrative tumorous subregions from normal tissue in brain gliomas using multiparametric MRI. Journal of Magnetic Resonance Imaging, 48(4), 938\u2013950.","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"1","key":"582_CR45","doi-asserted-by":"crossref","first-page":"160044","DOI":"10.1038\/sdata.2016.44","volume":"3","author":"KJ Gorgolewski","year":"2016","unstructured":"Gorgolewski, K. J., Auer, T., Calhoun, V. D., Craddock, R. C., Das, S., Duff, E. P., et al. (2016). The brain imaging data structure, a format for organizing and describing outputs of neuroimaging experiments. Scientific Data, 3(1), 160044.","journal-title":"Scientific Data"},{"issue":"1","key":"582_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1593\/tlo.13862","volume":"7","author":"J Kalpathy-Cramer","year":"2014","unstructured":"Kalpathy-Cramer, J., Freymann, J. B., Kirby, J. S., Kinahan, P. E., & Prior, F. W. (2014). Quantitative imaging network: Data sharing and competitive algorithmvalidation leveraging the cancer imaging archive. Translational Oncology, 7(1), 147\u2013152.","journal-title":"Translational Oncology"},{"issue":"7","key":"582_CR47","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1002\/jmri.26518","volume":"49","author":"A Shukla-Dave","year":"2019","unstructured":"Shukla-Dave, A., Obuchowski, N. A., Chenevert, T. L., Jambawalikar, S., Schwartz, L. H., Malyarenko, D., et al. (2019). Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. Journal of Magnetic Resonance Imaging, 49(7), e101\u2013e121.","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"582_CR48","unstructured":"EIBALL. (n.d.) European Imaging Biomarkers Alliance. https:\/\/www.myesr.org\/research\/esr-research-committee"},{"key":"582_CR49","unstructured":"OSIPI. (n.d.). Open Source Initiative for Perfusion Imaging. Retrieved June 19, 2020, from https:\/\/www.osipi.org\/."},{"issue":"9","key":"582_CR50","first-page":"1188","volume":"17","author":"BM Ellingson","year":"2015","unstructured":"Ellingson, B. M., Bendszus, M., Boxerman, J., Barboriak, D., Erickson, B. J., Smits, M., et al. (2015). Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro-Oncology, 17(9), 1188\u20131198.","journal-title":"Neuro-Oncology"},{"key":"582_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa141","author":"JL Boxerman","year":"2020","unstructured":"Boxerman, J. L., Quarles, C. C., Hu, L. S., Erickson, B. J., Gerstner, E. R., Smits, M., et al. (2020). Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. Neuro-Oncology. https:\/\/doi.org\/10.1093\/neuonc\/noaa141.","journal-title":"Neuro-Oncology"},{"issue":"1","key":"582_CR52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mrm.25197","volume":"73","author":"DC Alsop","year":"2015","unstructured":"Alsop, D. C., Detre, J. A., Golay, X., G\u00fcnther, M., Hendrikse, J., Hernandez-Garcia, L., et al. (2015). Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magnetic Resonance in Medicine, 73(1), 102\u2013116.","journal-title":"Magnetic Resonance in Medicine"},{"key":"582_CR53","doi-asserted-by":"crossref","first-page":"117031","DOI":"10.1016\/j.neuroimage.2020.117031","volume":"219","author":"HJMM Mutsaerts","year":"2020","unstructured":"Mutsaerts, H. J. M. M., Petr, J., Groot, P., Vandemaele, P., Ingala, S., Robertson, A. D., et al. (2020). ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies. NeuroImage, 219, 117031.","journal-title":"NeuroImage"},{"key":"582_CR54","unstructured":"ACR-ASNR-SPR. (2017). ACR\u2013ASNR\u2013SPR practice parameter for the performance of functional magnetic resonance imaging (fMRI) of the brain (Vol. No. Revised 2017, Resolution 20). ACR-ASNR-SPR."},{"issue":"2","key":"582_CR55","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/S1470-2045(19)30796-X","volume":"21","author":"TS Armstrong","year":"2020","unstructured":"Armstrong, T. S., Dirven, L., Arons, D., Bates, A., Chang, S. M., Coens, C., et al. (2020). Glioma patient-reported outcome assessment in clinical care and research: A Response Assessment in Neuro-Oncology collaborative report. The Lancet Oncology, 21(2), e97\u2013e103.","journal-title":"The Lancet Oncology"},{"issue":"7","key":"582_CR56","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/neuonc\/noz033","volume":"21","author":"D Schiff","year":"2019","unstructured":"Schiff, D., Van den Bent, M., Vogelbaum, M. A., Wick, W., Miller, C. R., Taphoorn, M., et al. (2019). Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus. Neuro-Oncology, 21(7), 837\u2013853.","journal-title":"Neuro-Oncology"},{"issue":"4","key":"582_CR57","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bpa.12832","volume":"30","author":"DN Louis","year":"2020","unstructured":"Louis, D. N., Wesseling, P., Aldape, K., Brat, D. J., Capper, D., Cree, I. A., et al. (2020). cIMPACT-NOW update 6: New entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathology, 30(4), 844\u2013856.","journal-title":"Brain Pathology"},{"issue":"7","key":"582_CR58","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/neuonc\/noy020","volume":"20","author":"Consortium, T. G","year":"2018","unstructured":"Consortium, T. G. (2018). Glioma through the looking GLASS: Molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium. Neuro-Oncology, 20(7), 873\u2013884.","journal-title":"Neuro-Oncology"},{"key":"582_CR59","unstructured":"European Cooperation in Science & Technology. (2020). CA18206\u2014glioma MR imaging 2.0. Retrieved June 19, 2020, from https:\/\/www.cost.eu\/actions\/CA18206\/#tabs|Name:overview."},{"key":"582_CR60","unstructured":"Glioma MR Imaging 2.0. (2020). Participants. Retrieved June 19, 2020, from https:\/\/glimr.eu\/about\/participants\/."},{"key":"582_CR61","unstructured":"European Network for Brain Imaging of Tumours. (2017). Data sharing & Tools for brain tumour imaging. Retrieved August 10, 2020, from https:\/\/en-brain-imaging-of-tumours.github.io\/website\/."},{"key":"582_CR62","unstructured":"European Network for Brain Imaging of Tumours. (2017). Public documentation of the European Network for Brain Imaging of Tumours. Retrieved August 10, 2020, from https:\/\/github.com\/EN-Brain-Imaging-of-Tumours\/doc."},{"key":"582_CR63","unstructured":"Glioma MR Imaging 2.0. (2020). Retrieved June 19, 2020, from www.glimr.eu."},{"key":"582_CR64","unstructured":"European Cooperation in Science & Technology. (2020). Excellence and Inclusiveness aiming to promote and spread excellence 2014\u20132020. Retrieved June 19, 2020, from https:\/\/www.cost.eu\/who-we-are\/cost-strategy\/excellence-and-inclusiveness\/."},{"key":"582_CR65","unstructured":"Open Brain Consent. (2020). Make open data sharing a no-brainer for ethics committees. Retrieved June 19, 2020, from https:\/\/open-brain-consent.readthedocs.io\/en\/stable\/."},{"key":"582_CR66","unstructured":"Open Brain Consent. (2020). Data user agreement and ultimate GDPR. Retrieved June 19, 2020, from https:\/\/github.com\/con\/open-brain-consent\/tree\/master\/docs\/source\/gdpr\/i18n."},{"key":"582_CR67","doi-asserted-by":"publisher","unstructured":"Bannier, E., Barker, G., Borghesani, V., Broeckx, N., Clement, P., de la Iglesia Vaya, M., et al. (2020). The open brain consent: Informing research participants and obtaining consent to share brain imaging data. https:\/\/doi.org\/10.31234\/osf.io\/f6mnp","DOI":"10.31234\/osf.io\/f6mnp"},{"key":"582_CR68","unstructured":"Glioma MR Imaging 2.0 COST Action. (2020). Youtube channel. Retrieved June 19, 2020, from https:\/\/www.youtube.com\/channel\/UCG4FyL6vywSwc8tInGfWyWw\/."},{"key":"582_CR69","unstructured":"European Cooperation in Science & Technology. (2020). Participate in an ongoing action. Retrieved August 10, 2020, from https:\/\/www.cost.eu\/cost-actions\/how-to-participate\/."},{"issue":"4","key":"582_CR70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1227\/NEU.0000000000001355","volume":"79","author":"N Verburg","year":"2016","unstructured":"Verburg, N., Pouwels, P. J. W., Boellaard, R., Barkhof, F., Hoekstra, O. S., Reijneveld, J. C., et al. (2016). Accurate delineation of glioma infiltration by advanced PET\/MR neuro-imaging (FRONTIER Study) A diagnostic study protocol. Neurosurgery, 79(4), 535\u2013540.","journal-title":"Neurosurgery"}],"container-title":["Journal of Medical and Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40846-020-00582-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40846-020-00582-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40846-020-00582-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T03:38:26Z","timestamp":1619321906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40846-020-00582-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1007\/s40846-020-00582-z","relation":{},"ISSN":["1609-0985","2199-4757"],"issn-type":[{"type":"print","value":"1609-0985"},{"type":"electronic","value":"2199-4757"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Marion Smits is \u2018speaker honoraria\u2019 from GE Healthcare, for which honoraria are paid to the author\u2019s institution. Vera C. Keil is an invited paid lecturer for Philips healthcare in Germany and Switzerland.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}